Tides Global is a media outlet that investigates the latest in oligo, peptide, mRNA, and genome editing therapeutic research. Through interviews, features, and cutting-edge reporting, it provides reliable journalistic coverage of everything from preclinical studies and clinical trial results to industry trends and regulatory news. Tides Global's international lens provides a holistic view of emerging drug modalities and the leading thinkers and scientists pushing the boundaries of drug development and CMC.